PharmaEssentia Medical Affairs is committed to partnering with healthcare professionals to provide medical and scientific information to support the appropriate use of our products and to help them make informed clinical decisions for the treatment of their patients. Please use the tool below to search our medical information library. By using this website you confirm the unsolicited nature of your request.
This information is provided in furtherance of ensuring accurate scientific information is available to healthcare professionals in response to their unsolicited requests, and should not be construed as an endorsement or promotion of indications or uses not discussed in the FDA-approved Prescribing Information. It is intended to provide pertinent data to assist you in forming your own conclusions in order to make healthcare decisions. A suspected adverse event or product complaint should be reported to firstname.lastname@example.org. Please review the full Prescribing Information for completeness with attention to the INDICATIONS AND USAGE, DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, and ADVERSE REACTIONS sections prior to use.
For additional information, contact the PharmaEssentia Medical Information team.
This section contains information relating to PharmaEssentia's approved products.
BESREMi® (ropeginterferon alfa-2b-njft)
Please see the full Prescribing Information, including Boxed Warning.
BESREMi is a registered trademark of PharmaEssentia Corporation.
You are now leaving this site and being directed to a site not maintained by PharmaEssentia.
PharmaEssentia is not responsible for content or privacy policies on other sites.